Similar articles for PMID: 27286795

Year	Number of Results
1999	1
2001	2
2002	2
2003	2
2004	3
2005	2
2006	1
2007	2
2008	4
2009	7
2010	10
2011	12
2012	13
2013	23
2014	22
2015	23
2016	24
2017	43
2018	39
2019	28
2020	42
2021	29
2022	26
2023	6
2024	0

1

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Välk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PØ, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H. Eskilsson E, et al. Neuro Oncol. 2016 Dec;18(12):1644-1655. doi: 10.1093/neuonc/now113. Epub 2016 Jun 10. Neuro Oncol. 2016. PMID: 27286795 Free PMC article.

2

GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.

Lindberg OR, McKinney A, Engler JR, Koshkakaryan G, Gong H, Robinson AE, Ewald AJ, Huillard E, David James C, Molinaro AM, Shieh JT, Phillips JJ. Lindberg OR, et al. Oncotarget. 2016 Nov 29;7(48):79101-79116. doi: 10.18632/oncotarget.12600. Oncotarget. 2016. PMID: 27738329 Free PMC article.

3

EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.

Liu Z, Han L, Dong Y, Tan Y, Li Y, Zhao M, Xie H, Ju H, Wang H, Zhao Y, Zheng Q, Wang Q, Su J, Fang C, Fu S, Jiang T, Liu J, Li X, Kang C, Ren H. Liu Z, et al. Oncotarget. 2016 Jan 26;7(4):4680-94. doi: 10.18632/oncotarget.6730. Oncotarget. 2016. PMID: 26717039 Free PMC article.

4

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.

Camorani S, Crescenzi E, Colecchia D, Carpentieri A, Amoresano A, Fedele M, Chiariello M, Cerchia L. Camorani S, et al. Oncotarget. 2015 Nov 10;6(35):37570-87. doi: 10.18632/oncotarget.6066. Oncotarget. 2015. PMID: 26461476 Free PMC article.

5

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.

Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Vengoji R, et al. J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2. J Exp Clin Cancer Res. 2019. PMID: 31215502 Free PMC article.

6

F25P preproinsulin abrogates the secretion of pro-growth factors from EGFRvIII cells and suppresses tumor growth in an EGFRvIII/wt heterogenic model.

Wei JW, Cui JQ, Zhou X, Fang C, Tan YL, Chen LY, Yang C, Liu M, Kang CS. Wei JW, et al. Cancer Lett. 2016 Sep 28;380(1):1-9. doi: 10.1016/j.canlet.2016.06.006. Epub 2016 Jun 15. Cancer Lett. 2016. PMID: 27317648

7

EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.

Keller S, Schmidt MHH. Keller S, et al. Int J Mol Sci. 2017 Jun 18;18(6):1295. doi: 10.3390/ijms18061295. Int J Mol Sci. 2017. PMID: 28629170 Free PMC article. Review.

8

Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.

Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz M, Spang-Thomsen M, Poulsen HS. Stockhausen MT, et al. Exp Cell Res. 2011 Jul 1;317(11):1513-26. doi: 10.1016/j.yexcr.2011.04.001. Epub 2011 Apr 15. Exp Cell Res. 2011. PMID: 21514294

9

Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.

Hu L, Shen D, Liang D, Shi J, Song C, Jiang K, Menglin Ren, Du S, Cheng W, Ma J, Li S, Bi X, Barr MP, Fang Z, Xu Q, Li W, Piao H, Meng S. Hu L, et al. Cancer Lett. 2020 Nov 28;493:156-166. doi: 10.1016/j.canlet.2020.08.023. Epub 2020 Aug 27. Cancer Lett. 2020. PMID: 32860853

10

Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.

Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A. Micallef J, et al. Cancer Res. 2009 Oct 1;69(19):7548-56. doi: 10.1158/0008-5472.CAN-08-4783. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

330 results

Results by year